MARKET

XOMA

XOMA

XOMA Royalty Corporation
NASDAQ
26.76
-0.30
-1.11%
After Hours: 26.76 0 0.00% 16:01 02/14 EST
OPEN
27.08
PREV CLOSE
27.06
HIGH
27.21
LOW
26.76
VOLUME
16.29K
TURNOVER
--
52 WEEK HIGH
35.00
52 WEEK LOW
19.50
MARKET CAP
315.31M
P/E (TTM)
-8.3245
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at XOMA last week (0203-0207)?
Weekly Report · 6d ago
Forecasting The Future: 5 Analyst Projections For XOMA Royalty
Benzinga · 02/03 21:00
Weekly Report: what happened at XOMA last week (0127-0131)?
Weekly Report · 02/03 11:41
XOMA Price Target Cut to $104.00/Share From $123.00 by HC Wainwright & Co.
Dow Jones · 02/03 11:39
XOMA Is Maintained at Buy by HC Wainwright & Co.
Dow Jones · 02/03 11:39
HC Wainwright & Co. Maintains Buy on XOMA Royalty, Lowers Price Target to $104
Benzinga · 02/03 11:29
Xoma price target lowered to $104 from $123 at H.C. Wainwright
TipRanks · 02/03 11:10
Weekly Report: what happened at XOMA last week (0120-0124)?
Weekly Report · 01/27 11:45
More
About XOMA
XOMA Royalty Corporation is a biotechnology royalty aggregator. The Company’s royalty aggregator business is primarily focused on early to mid-stage clinical assets, primarily in Phase I and II, with significant commercial sales potential that are licensed to larger pharmaceutical partners. The Company has a portfolio of economic rights and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The Company's royalty portfolio includes OJEMDA (tovorafenib), JNJ-63723283 (cetrelimab), RZ358, arimoclomol, mezagitamab (TAK-079), acimtamig (AFM13), AB054, ficlatuzumab (AV-299), COM902, vosaroxin, aldoxorubicin, INCAGN02385, INCAGN02390, MNPR-101, PBF-680, PBF-677, PBF-999, PBF-1129, PBF-1650, RZ402, DSUVIA (sufentanil sublingual tablet), IXINITY [coagulation factor IX (recombinant)], CMP-001 (vidutolimod), NTM-1631, NTM-1634, NTM-1633, NTM-1632, NIR178, MK-4830, AFM24, INCAGN01949, AB101, and CFZ533 (iscalimab).

Webull offers XOMA Royalty Corp stock information, including NASDAQ: XOMA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, XOMA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading XOMA stock methods without spending real money on the virtual paper trading platform.